XML 24 R7.htm IDEA: XBRL DOCUMENT v3.24.0.1
Consolidated Statements of Changes in Shareholders' Equity - USD ($)
$ in Thousands
Total
Cumulative effect, period of adoption, adjustment
Common Stock
Additional Paid-in Capital
 Retained Earnings
 Retained Earnings
Cumulative effect, period of adoption, adjustment
Accumulated Other Comprehensive Income (Loss)
Beginning balance (in shares) at Dec. 31, 2020     6,251,000        
Beginning balance, value at Dec. 31, 2020 $ 221,575 $ 2,400 $ 6,251 $ 41,808 $ 173,498 $ 2,400 $ 18
Increase (Decrease) in Stockholders' Equity [Roll Forward]              
Cash dividend declared (9,369)       (9,369)    
Stock-based compensation expense 1,073     1,073      
Exercise of stock options and vesting of restricted stock units, net (in shares)     43,000        
Exercise of stock options and vesting of restricted stock units, net (421)   $ 43 (464)      
Repurchase of common stock (in shares)     (279,000)        
Repurchase of common stock (11,534)   $ (279) (11,255)      
Other comprehensive income (loss), net of tax (3,424)           (3,424)
Net income 37,517       37,517    
Ending balance (in shares) at Dec. 31, 2021     6,015,000        
Ending balance, value at Dec. 31, 2021 237,817   $ 6,015 31,162 204,046   (3,406)
Increase (Decrease) in Stockholders' Equity [Roll Forward]              
Cash dividend declared (10,562)       (10,562)    
Stock-based compensation expense 742     742      
Exercise of stock options and vesting of restricted stock units, net (in shares)     20,000        
Exercise of stock options and vesting of restricted stock units, net (277)   $ 20 (297)      
Repurchase of common stock (in shares)     (334,000)        
Repurchase of common stock (14,157)   $ (334) (13,823)      
Other comprehensive income (loss), net of tax (25,675)           (25,675)
Net income $ 30,741       30,741    
Ending balance (in shares) at Dec. 31, 2022 5,700,728   5,701,000        
Ending balance, value at Dec. 31, 2022 $ 218,629   $ 5,701 17,784 224,225   (29,081)
Increase (Decrease) in Stockholders' Equity [Roll Forward]              
Cash dividend declared (13,582)       (13,582)    
Stock-based compensation expense 937     937      
Exercise of stock options and vesting of restricted stock units, net (in shares)     21,000        
Exercise of stock options and vesting of restricted stock units, net (260)   $ 21 (281)      
Repurchase of common stock (in shares)     (209,000)        
Repurchase of common stock (9,044)   $ (209) (8,835)      
Other comprehensive income (loss), net of tax 12,644           12,644
Net income $ 25,394       25,394    
Ending balance (in shares) at Dec. 31, 2023 5,513,459   5,513,000        
Ending balance, value at Dec. 31, 2023 $ 234,718   $ 5,513 $ 9,605 $ 236,037   $ (16,437)